ADAPTIMMUNE THERAPEUTICS PLC Cash and Cash Equivalents, Period Increase (Decrease)
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$53.82 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2016-11-10
- ADAPTIMMUNE THERAPEUTICS PLC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was -$10.45M.
- ADAPTIMMUNE THERAPEUTICS PLC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-06-30 was -$12.87M, a 109.43% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-31 was -$30.50M.
- ADAPTIMMUNE THERAPEUTICS PLC cash and cash equivalents, period increase (decrease) for the quarter ending 2015-09-30 was -$11.83M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2016-09-30 | -$10.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$23.33M derived: sum of 2 quarters · filed 2016-11-10 | -$53.82M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | -$12.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$43.37M 10-Q · filed 2016-08-08 | ||
| 2016-03-31 | -$30.50M 10-Q · filed 2016-05-12 | |||
| 2015-12-31 | -$34.78M 8-K · filed 2016-07-08 | |||
| 2015-09-30 | -$11.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $124.62M derived: sum of 2 quarters · filed 2016-11-10 | $115.55M 10-Q · filed 2016-11-10 | |
| 2015-06-30 | $136.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $127.38M 10-Q · filed 2016-08-08 | $177.87M 8-K · filed 2016-07-08 | |
| 2015-03-31 | -$9.06M 10-Q · filed 2016-05-12 | |||
| 2014-06-30 | $51.18M 8-K · filed 2016-07-08 | |||
| 2013-06-30 | -$3.11M 8-K · filed 2016-07-08 |